Protara Therapeutics, Inc. — Director's Dealing 2015

Mar 25, 2015

SEC Form 3/A — Form 3/A

Issuer: PROTEON THERAPEUTICS INC (PRTO)
CIK: 0001359931
Period of Report: 2014-10-21

Reporting Person: O'Leary Brendan (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$10.00	2024-10-21	Common Stock (6666)		Direct

Footnotes

F1: The Form 3 filed on October 21, 2014 omitted the Stock Option shares awarded to Brendan O'Leary.

F2: The shares underlying this option vest 100% on the date of the next annual meeting of stockholders.